Adimab LLC 13D and 13G filings for Invivyd, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 4:15 pm Sale |
2024-01-19 | 13D | Invivyd, Inc. IVVD |
Adimab LLC | 21,687,906 19.700% |
-5,000,000 (-18.74%) |
Filing |
| 2022-06-24 4:54 pm Unchanged |
2022-06-22 | 13D | Invivyd, Inc. IVVD |
Adimab LLC | 26,687,906 24.300% |
0 (Unchanged) |
Filing |
| 2022-04-25 8:11 pm Unchanged |
2022-04-25 | 13D | Invivyd, Inc. IVVD |
Adimab LLC | 26,687,906 24.300% |
0 (Unchanged) |
Filing |
| 2022-03-30 4:21 pm Purchase |
2022-03-28 | 13D | Invivyd, Inc. IVVD |
Adimab LLC | 26,687,906 24.000% |
26,687,906 (New Position) |
Filing |